{
    "name": "tofersen",
    "comment": "Rx",
    "other_names": [
        "Qalsody"
    ],
    "classes": [
        "Neurologics",
        "Antisense Oligonucleotides"
    ],
    "source": "https://reference.medscape.com/drug/tofersen-4000306",
    "pregnancy": {
        "common": [
            "There are no adequate data on developmental risks associated with use in pregnant females to evaluate for drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes"
        ],
        "specific": [
            {
                "type": "Animal studies ",
                "description": [
                    "SC administration (0, 3, 10, 30 mg/kg) every other day to pregnant mice during organogenesis resulted in no adverse effects on embryofetal development; plasma exposure at highest dose tested (30 mg/kg) was ~4 times that in humans at the recommended human dose (RHD) of 100 mg",
                    "Similarly, SC administration to pregnant rabbits during the period of organogenesis resulted in no adverse effects on embryofetal development; plasma exposure at the highest dose tested (30 mg/kg) was ~20 times that in humans at the RHD"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Pain",
            "percent": "42"
        },
        {
            "name": "Fatigue",
            "percent": "17"
        },
        {
            "name": "Arthralgia",
            "percent": "14"
        },
        {
            "name": "Cerebrospinal fluid",
            "percent": "14"
        },
        {
            "name": "CSF",
            "percent": "14"
        },
        {
            "name": "WBCs increased",
            "percent": "8"
        },
        {
            "name": "Myalgia",
            "percent": "6"
        },
        {
            "name": "CSF protein increased",
            "percent": "6"
        },
        {
            "name": "Musculoskeletal stiffness",
            "percent": null
        },
        {
            "name": "Neuralgia",
            "percent": null
        },
        {
            "name": "Myelitis",
            "percent": null
        },
        {
            "name": "Radiculitis",
            "percent": null
        },
        {
            "name": "Papilledema",
            "percent": null
        },
        {
            "name": "Elevated intracranial pressure",
            "percent": null
        },
        {
            "name": "ICP",
            "percent": null
        },
        {
            "name": "Aseptic meningitis",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        }
    ]
}